Apyx Medical (APYX) Change in Account Payables (2011 - 2026)
Apyx Medical's (APYX) quarterly Change in Account Payables came in at -$444000.0 in Q2 2026, down 186.55% on a YoY basis from $513000.0 in Q2 2025, and down 8.03% quarter-over-quarter from -$411000.0 in Q1 2026.
Powered by 
Analysis
Apyx Medical (APYX) Change in Account Payables (2011 - 2026) Analysis & Trends
Apyx Medical (APYX) has reported Change in Account Payables for 16 consecutive years, with -$444000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Account Payables fell 186.55% year-over-year to -$444000.0; the trailing twelve-month figure through Jun 2026 stood at -$682000.0 (down 246.98% YoY), and the FY2025 full-year result was $355000.0, up 663.49% from the prior year.
- Change in Account Payables eased to -$444000.0 in Q2 2026 per APYX's latest filing, from -$411000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $756000.0 in Q4 2024 and bottomed at -$776000.0 in Q1 2023.
- Historically, Change in Account Payables has averaged -$26166.7 across 5 years, with a median of -$103000.0 in 2022.
- The widest YoY moves for Change in Account Payables: up 792.86% in 2023, down 1421.57% in 2023.
- Over 5 years, Change in Account Payables stood at $506000.0 in 2022, then advanced by 26.09% to $638000.0 in 2023, then increased by 18.5% to $756000.0 in 2024, then slumped by 120.5% to -$155000.0 in 2025, then tumbled by 186.45% to -$444000.0 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$444000.0, -$411000.0, and -$155000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.77 Bn | 175.17 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.65 Bn | 122.43 Bn | 1.96 Bn | -52.50 Mn |
| 3 | Medtronic | 117.15 Bn | 108.33 Bn | 6.34 Bn | - |
| 4 | Stryker | 104.21 Bn | 100.73 Bn | 4.50 Bn | 71.00 Mn |
| 5 | Boston Scientific | 63.46 Bn | 62.92 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.73 Bn | 45.48 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.01 Bn | 31.56 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.17 Bn | 30.22 Bn | 830.00 Mn | - |
| 9 | Steris | 20.72 Bn | 20.24 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Apyx Medical | 130.67 Mn | 103.06 Mn | 8.87 Mn | -444,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -444,000.00 |
| Mar 31, 2026 | -411,000.00 |
| Dec 31, 2025 | -155,000.00 |
| Sep 30, 2025 | 328,000.00 |
| Jun 30, 2025 | 513,000.00 |
| Mar 31, 2025 | -331,000.00 |
| Dec 31, 2024 | 756,000.00 |
| Sep 30, 2024 | -474,000.00 |
| Jun 30, 2024 | 254,000.00 |
| Mar 31, 2024 | -599,000.00 |
| Dec 31, 2023 | 638,000.00 |
| Sep 30, 2023 | -587,000.00 |
| Jun 30, 2023 | 750,000.00 |
| Mar 31, 2023 | -776,000.00 |
| Dec 31, 2022 | 506,000.00 |
| Sep 30, 2022 | -472,000.00 |
| Jun 30, 2022 | 84,000.00 |
| Mar 31, 2022 | -51,000.00 |
| Dec 31, 2021 | -401,000.00 |
| Sep 30, 2021 | 259,000.00 |